COM:TARSUSRX
Tarsus Pharmaceuticals, Inc.
- Stock
Last Close
46.40
22/11 21:00
Market Cap
1.07B
Beta: -
Volume Today
589.21K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
average inventory | 2.38M - | 3.93M 65.24% | |||||
average payables | 315.50K - | 1.35M 326.78% | 5.46M 305.38% | 9.29M 70.28% | 4.96M 46.69% | ||
average receivables | 20K - | 28K 40% | 56K 100% | 1.84M 3,180.36% | 10.65M 479.64% | ||
book value per share | -0.32 - | -2.54 704.36% | 26.74 1,152.10% | 8.11 69.66% | 7.84 3.41% | 0.01 99.91% | |
capex per share | -0.00 - | -0.07 4,434.15% | -0.07 0.82% | -0.03 61.19% | -0.02 27.91% | -0.00 99.75% | |
capex to depreciation | -7 - | -4.73 32.43% | -4.75 0.43% | -1.88 60.46% | -1.56 17.11% | -1.71 10.00% | |
capex to operating cash flow | 0.01 - | 0.05 705.20% | 0.02 54.72% | -0.16 824.76% | 0.01 106.60% | 0.01 23.87% | |
capex to revenue | -0.01 - | -0.02 90.74% | -0.09 339.23% | ||||
cash per share | 0.55 - | 24.53 4,363.07% | 27.09 10.43% | 8.36 69.14% | 8.82 5.45% | 0.01 99.91% | |
days of inventory on hand | 1.82K - | 711.90 60.89% | |||||
days payables outstanding | 1.53K - | 3.79K 148.07% | |||||
days sales outstanding | 0.59 - | 50.64 8,500.61% | 370.59 631.74% | ||||
debt to assets | 0.00 - | 0.00 71.83% | 0.01 118.74% | 0.09 736.84% | |||
debt to equity | -0.03 - | 0.01 118.33% | 0.01 126.53% | 0.10 821.24% | |||
dividend yield | |||||||
earnings yield | -0.01 - | -0.10 542.14% | -0.10 8.82% | -0.03 71.39% | -0.17 475.39% | -0.00 99.87% | |
enterprise value | 85.84M - | -9.16M 110.67% | 89.25M 1,074.13% | 293.03M 228.31% | 309.42M 5.59% | 594.79B 192,126.35% | |
enterprise value over ebitda | -63.63 - | 2.33 103.66% | -3.32 242.31% | -27.70 734.88% | -5.23 81.11% | -4.15K 79,293.17% | |
ev to operating cash flow | -72.56 - | 2.49 103.44% | -4.22 269.27% | 78.18 1,951.61% | -6.31 108.07% | -5.06K 80,116.34% | |
ev to sales | 5.14 - | 11.99 133.26% | 34.09K 284,333.74% | ||||
free cash flow per share | -0.28 - | -1.63 486.47% | -3.48 113.61% | 0.15 104.42% | -2.01 1,407.90% | -0.00 99.80% | |
free cash flow yield | -0.01 - | -0.08 486.47% | -0.08 6.36% | 0.01 108.12% | -0.14 2,107.35% | -0.00 99.85% | |
graham net net | -0.32 - | -2.68 730.49% | 26.12 1,073.22% | 7.77 70.26% | 7.60 2.18% | 0.01 99.92% | |
graham number | 1.48 - | 10.63 618.69% | 50.98 379.49% | 11.08 78.26% | 21.09 90.29% | 0.03 99.87% | |
income quality | 0.90 - | 0.79 12.31% | 0.79 0.24% | -0.27 134.38% | 0.79 391.31% | 0.86 9.49% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0.01 Infinity% | |
interest coverage | -143.61 - | -28.52 - | 42.78 250.03% | ||||
interest debt per share | 0.07 - | 0.16 136.51% | 0.09 43.96% | 0.91 886.91% | -0.00 100.01% | ||
inventory turnover | 0.20 - | 0.51 155.67% | |||||
invested capital | -0.03 - | 0.01 118.33% | 0.01 126.53% | 0.10 821.24% | |||
market cap | 88.19M - | 48.63M 44.86% | 256.55M 427.60% | 462.47M 80.26% | 360.92M 21.96% | 595.01B 164,757.43% | |
net current asset value | -1.36M - | -6.29M 362.57% | 164.66M 2,717.44% | 163.78M 0.54% | 190.41M 16.26% | 187.63M 1.46% | |
net debt to ebitda | 1.75 - | 14.70 742.30% | 6.22 57.71% | 16.02 157.55% | 0.87 94.56% | 1.57 80.39% | |
net income per share | -0.31 - | -1.98 542.14% | -4.32 118.53% | -0.67 84.43% | -2.52 274.90% | -0.00 99.82% | |
operating cash flow per share | -0.28 - | -1.55 463.11% | -3.41 119.06% | 0.18 105.35% | -1.99 1,192.14% | -0.00 99.80% | |
payables turnover | 0.24 - | 0.10 59.69% | |||||
receivables turnover | 619.86 - | 7.21 98.84% | 0.98 86.33% | ||||
research and ddevelopement to revenue | 0.73 - | 1.65 125.73% | 2.88 74.66% | ||||
return on tangible assets | -0.55 - | -0.08 85.50% | -0.16 94.68% | -0.08 50.43% | -0.27 252.58% | -0.52 90.62% | |
revenue per share | 2.77 - | 1.05 62.21% | 0.00 99.94% | ||||
roe | 0.97 - | 0.78 20.17% | -0.16 120.77% | -0.08 48.66% | -0.32 288.13% | -0.69 114.32% | |
roic | 1.00 - | 0.76 24.11% | -0.16 121.27% | -0.07 55.55% | -0.29 309.69% | -0.73 147.81% | |
sales general and administrative to revenue | 0.45 - | 1.74 290.96% | |||||
shareholders equity per share | -0.32 - | -2.54 704.36% | 26.74 1,152.10% | 8.11 69.66% | 7.84 3.41% | 0.01 99.91% | |
stock based compensation to revenue | 0.15 - | 0.52 251.66% | 1.14 117.99% | ||||
tangible asset value | -1.35M - | -6.00M 343.50% | 165.98M 2,864.03% | 166.73M 0.45% | 192.90M 15.70% | 193.12M 0.11% | |
tangible book value per share | -0.32 - | -2.54 704.36% | 26.74 1,152.10% | 8.11 69.66% | 7.84 3.41% | 0.01 99.92% | |
working capital | 2.20M - | 57.21M 2,495.78% | 165.27M 188.87% | 164.47M 0.48% | 209.95M 27.65% | 219.19M 4.41% |
All numbers in USD (except ratios and percentages)